Sandra Fontanière

902 total citations
12 papers, 669 citations indexed

About

Sandra Fontanière is a scholar working on Molecular Biology, Epidemiology and Oncology. According to data from OpenAlex, Sandra Fontanière has authored 12 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 6 papers in Epidemiology and 5 papers in Oncology. Recurrent topics in Sandra Fontanière's work include Neuroendocrine Tumor Research Advances (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and CRISPR and Genetic Engineering (3 papers). Sandra Fontanière is often cited by papers focused on Neuroendocrine Tumor Research Advances (6 papers), Pancreatic and Hepatic Oncology Research (3 papers) and CRISPR and Genetic Engineering (3 papers). Sandra Fontanière collaborates with scholars based in France, Germany and China. Sandra Fontanière's co-authors include Chang Zhang, Ignacio Anegón, Alexandre Fraichard, Laurent Tesson, Reynald Thinard, Séverine Ménoret, Anne De Cian, Carine Giovannangeli, Jean‐Paul Concordet and Charlotte Boix and has published in prestigious journals such as Journal of Biological Chemistry, Oncogene and Scientific Reports.

In The Last Decade

Sandra Fontanière

12 papers receiving 659 citations

Peers

Sandra Fontanière
Sisi Lai China
Alicia Lindeman Switzerland
Michaela Willi United States
Richard Van Rheeden United States
Kevin A. Hoegenauer United States
Dekker C. Deacon United States
Yi Fu United States
Sisi Lai China
Sandra Fontanière
Citations per year, relative to Sandra Fontanière Sandra Fontanière (= 1×) peers Sisi Lai

Countries citing papers authored by Sandra Fontanière

Since Specialization
Citations

This map shows the geographic impact of Sandra Fontanière's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sandra Fontanière with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sandra Fontanière more than expected).

Fields of papers citing papers by Sandra Fontanière

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sandra Fontanière. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sandra Fontanière. The network helps show where Sandra Fontanière may publish in the future.

Co-authorship network of co-authors of Sandra Fontanière

This figure shows the co-authorship network connecting the top 25 collaborators of Sandra Fontanière. A scholar is included among the top collaborators of Sandra Fontanière based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sandra Fontanière. Sandra Fontanière is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Renaud, Jean-Baptiste, Charlotte Boix, Marine Charpentier, et al.. (2016). Improved Genome Editing Efficiency and Flexibility Using Modified Oligonucleotides with TALEN and CRISPR-Cas9 Nucleases. Cell Reports. 14(9). 2263–2272. 221 indexed citations
2.
Ménoret, Séverine, Anne De Cian, Laurent Tesson, et al.. (2015). Homology-directed repair in rodent zygotes using Cas9 and TALEN engineered proteins. Scientific Reports. 5(1). 14410–14410. 65 indexed citations
3.
Ménoret, Séverine, Sandra Fontanière, Derek Jantz, et al.. (2012). Generation of Rag1 ‐knockout immunodeficient rats and mice using engineered meganucleases. The FASEB Journal. 27(2). 703–711. 79 indexed citations
4.
Lu, Jieli, Rémy Bonnavion, Nirmitha I. Herath, et al.. (2011). Reexpression of oncoprotein MafB in proliferative β-cells and Men1 insulinomas in mouse. Oncogene. 31(31). 3647–3654. 33 indexed citations
5.
Fontanière, Sandra, Christine Carreira, Jieli Lu, et al.. (2010). Characterisation of prostate cancer lesions in heterozygous Men1 mutant mice. BMC Cancer. 10(1). 395–395. 20 indexed citations
6.
Hussein, Nawfal R, Jing Lü, Huguette Casse, et al.. (2008). Deregulation of anti-Mullerian hormone/BMP and transforming growth factor-  pathways in Leydig cell lesions developed in male heterozygous multiple endocrine neoplasia type 1 mutant mice. Endocrine Related Cancer. 15(1). 217–227. 14 indexed citations
7.
Fontanière, Sandra, Bertrand Duvillié, Raphaël Scharfmann, et al.. (2008). Tumour suppressor menin is essential for development of the pancreatic endocrine cells. Journal of Endocrinology. 199(2). 287–298. 20 indexed citations
8.
Fontanière, Sandra, Delphine Magnin, Olga Anczuków, et al.. (2008). Comparison of nonsense-mediated mRNA decay efficiency in various murine tissues. BMC Genetics. 9(1). 83–83. 100 indexed citations
9.
Fontanière, Sandra, Huguette Casse, Philippe Bertolino, & Chang Zhang. (2006). Analysis of p27Kip1 Expression in Insulinomas Developed in Pancreatic β-cell Specific Men1 Mutant Mice. Familial Cancer. 5(1). 49–54. 14 indexed citations
10.
Hussein, Nader, Huguette Casse, Sandra Fontanière, et al.. (2006). Reconstituted expression of menin in Men1-deficient mouse Leydig tumour cells induces cell cycle arrest and apoptosis. European Journal of Cancer. 43(2). 402–414. 25 indexed citations
11.
Fontanière, Sandra, Jörg Tost, Anne Wierinckx, et al.. (2006). Gene expression profiling in insulinomas of Men1 β-cell mutant mice reveals early genetic and epigenetic events involved in pancreatic β-cell tumorigenesis. Endocrine Related Cancer. 13(4). 1223–1236. 39 indexed citations
12.
Ratineau, Christelle, Christine Bernard, Gilles Poncet, et al.. (2004). Reduction of Menin Expression Enhances Cell Proliferation and Is Tumorigenic in Intestinal Epithelial Cells. Journal of Biological Chemistry. 279(23). 24477–24484. 39 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026